Holen Sie sich die Stockscreener-App
31.72
2.76%
-0.90
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TNDM?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$32.62
Offen:
$32.35
24-Stunden-Volumen:
848.21K
Relative Volume:
0.78
Marktkapitalisierung:
$2.08B
Einnahmen:
$796.00M
Nettoeinkommen (Verlust:
$-136.49M
KGV:
-15.18
EPS:
-2.09
Netto-Cashflow:
$-64.24M
1W Leistung:
-3.62%
1M Leistung:
-9.76%
6M Leistung:
-30.61%
1J Leistung:
+29.89%
1-Tages-Spanne:
$31.53
$32.62
1-Wochen-Bereich:
$31.53
$34.35
52-Wochen-Spanne:
$22.03
$53.69
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
Firmenname
Tandem Diabetes Care Inc
Sektor
Branche
Telefon
858-366-6900
Adresse
12400 HIGH BLUFF DRIVE, San Diego, CA
Vergleichen Sie TNDM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TNDM
Tandem Diabetes Care Inc
|
31.72 | 2.08B | 796.00M | -136.49M | -64.24M | -2.09 |
|
ABT
Abbott Laboratories
|
132.13 | 229.17B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.67 | 155.74B | 16.75B | 1.85B | 1.89B | 1.25 |
|
SYK
Stryker Corp
|
388.52 | 148.25B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
87.00 | 111.64B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
74.67 | 44.04B | 5.72B | 4.17B | 490.10M | 6.97 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-06 | Eingeleitet | Bernstein | Outperform |
| 2024-10-04 | Eingeleitet | Goldman | Neutral |
| 2024-10-02 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-08-22 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-08-08 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-05-30 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-05-22 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-04-29 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-04-25 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-03-26 | Hochstufung | Stifel | Hold → Buy |
| 2023-08-04 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-05-05 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-04-24 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-01-26 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-11-15 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-08-09 | Herabstufung | Wells Fargo | Overweight → Underweight |
| 2022-03-02 | Fortgesetzt | BofA Securities | Neutral |
| 2022-01-19 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-07-21 | Fortgesetzt | Cowen | Outperform |
| 2021-05-25 | Eingeleitet | Barclays | Underweight |
| 2020-12-15 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-08-20 | Eingeleitet | Wells Fargo | Overweight |
| 2020-07-31 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-07-06 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-06-18 | Bestätigt | Raymond James | Outperform |
| 2020-04-24 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-03-23 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2020-02-06 | Eingeleitet | Raymond James | Outperform |
| 2020-02-04 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-10-18 | Eingeleitet | Guggenheim | Buy |
| 2019-10-04 | Hochstufung | UBS | Neutral → Buy |
| 2019-05-17 | Bestätigt | BofA/Merrill | Neutral |
| 2019-05-13 | Eingeleitet | SVB Leerink | Outperform |
| 2019-03-08 | Eingeleitet | BMO Capital Markets | Outperform |
| 2019-03-05 | Bestätigt | BofA/Merrill | Neutral |
| 2019-02-27 | Bestätigt | Lake Street | Buy |
| 2018-11-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2018-09-26 | Bestätigt | Dougherty & Company | Buy |
| 2018-09-26 | Bestätigt | Piper Jaffray | Overweight |
Alle ansehen
Tandem Diabetes Care Inc Aktie (TNDM) Neueste Nachrichten
Trend Tracker for (TNDM) - Stock Traders Daily
Large Volume Wearable Injectors Market to Reach USD 8,482.4 Million by 2035 at 8.9% of CAGR, Driven by Self-Administration & Home Care | Future Market Insights, Inc. - Yahoo Finance
Reasons to Retain TNDM Stock in Your Portfolio for Now - MSN
Tandem Diabetes Care Announces Upcoming Conference Presentations - The Bakersfield Californian
Exclusive Healthcare Conference Schedule: Tandem Diabetes Care's March Investor Roadshow Revealed - StockTitan
Stephens Investment Management Group LLC Acquires 281,327 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
abrdn plc Has $8.96 Million Holdings in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
Mirae Asset Global Investments Co. Ltd. Has $11.12 Million Stock Holdings in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
How to Take Advantage of moves in (TNDM) - Stock Traders Daily
Tandem Diabetes Care (NASDAQ:TNDM) shareholders have endured a 69% loss from investing in the stock three years ago - Simply Wall St
Janney Montgomery Scott LLC Boosts Stock Holdings in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - Defense World
Chicago Capital LLC Sells 32,540 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
Jennison Associates LLC Lowers Holdings in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
KBC Group NV Grows Position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
Nisa Investment Advisors LLC Sells 4,559 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - Defense World
(TNDM) Trading Advice - Stock Traders Daily
Tandem Diabetes Gains 45.7% in a Year: What's Driving the Stock? - MSN
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Shares Bought by Park Avenue Securities LLC - Defense World
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Beacon Investment Advisory Services Inc. Cuts Position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
Infusion Devices Market to Reach US$ 23.08 Billion by 2031, Driven by Rising Prevalence of Infectious Diseases - GlobeNewswire Inc.
Artificial Pancreas Market is Predicted to Achieve Huge Growth - openPR
Assenagon Asset Management S.A. Decreases Stake in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
Tandem Diabetes Care (NASDAQ:TNDM) Stock Price Down 4%Time to Sell? - MarketBeat
Is There An Opportunity With Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM) 47% Undervaluation? - Simply Wall St
(TNDM) Long Term Investment Analysis - Stock Traders Daily
Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025 - Business Wire
Tandem Diabetes Care Sets Q4 and Full Year 2024 Earnings Release for February 26 - StockTitan
JPMorgan Chase & Co. Buys 113,355 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
UVA Center for Diabetes Technology, Tandem Diabetes Care to Research Fully Automated Insulin Delivery - Cville Right Now
Tandem Diabetes Forges New R&D Agreement With UVA: Stock to Gain? - MSN
Advancing R&D of fully automated insulin delivery systems - Today's Medical Developments
automated insulin delivery systems - Today's Medical Developments
UVA Center for Diabetes to participate in research of auto insulin delivery - Augusta Free Press
When (TNDM) Moves Investors should Listen - Stock Traders Daily
Tandem inks collab with UVA to develop closed-loop automated insulin delivery tech - Drug Delivery Business News
Tandem Diabetes Care, Inc. Enters Multi-Year Research Collaboration with UVA Center for Diabetes Technology for Development of Advanced Insulin Delivery Systems - Marketscreener.com
Tandem Diabetes Care Enters Multi-Year Research Collaboration with UVA Center for Diabetes Technology for Development of Advanced Insulin Delivery Systems - BioSpace
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Principal Financial Group Inc. Sells 77,771 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
How the (TNDM) price action is used to our Advantage - Stock Traders Daily
Is Tandem Diabetes Care (NASDAQ:TNDM) Weighed On By Its Debt Load? - Simply Wall St
Insulin Pump Market Insights: Key Drivers, Competitive - openPR
ROSEN, A TOP RANKED LAW FIRM, Encourages Tandem Diabetes Care, I - GuruFocus.com
Insulin Pump Market Valuation to Jump to Reach US$ 25.40 Billion by 2033 | India and China Offering Lucrative Growth Opportunities Says Astute Analytica - Yahoo Finance
Geode Capital Management LLC Has $64.72 Million Holdings in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat
New partnerships, approvals pump prospects for insulin delivery devices - BioWorld Online
Finanzdaten der Tandem Diabetes Care Inc-Aktie (TNDM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.14%
11.52%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):